Urine Analysis - Global Medical Devices Pipeline Assessment Report, 2019 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 19, 2019--
The “Urine Analysis - Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.
This report provides an overview of Urine Analysis currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analysis pipeline products.
- Extensive coverage of the Urine Analysis under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Urine Analysis and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Urine Analysis under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered
1 Table of Contents
2.1 Urine Analysis Overview
3 Products under Development
3.1 Urine Analysis - Pipeline Products by Stage of Development
3.2 Urine Analysis - Pipeline Products by Segment
3.3 Urine Analysis - Pipeline Products by Territory
3.4 Urine Analysis - Pipeline Products by Regulatory Path
3.5 Urine Analysis - Pipeline Products by Estimated Approval Date
3.6 Urine Analysis - Ongoing Clinical Trials
4 Urine Analysis - Pipeline Products under Development by Companies
4.1 Urine Analysis Companies - Pipeline Products by Stage of Development
4.2 Urine Analysis - Pipeline Products by Stage of Development
5 Urine Analysis Companies and Product Overview
- Company Overview
- Pipeline Products & Ongoing Clinical Trials Overview
5.1 Analyticon Biotechnologies AG
5.1.1 Analyticon Biotechnologies AG
5.2 Arkray Inc.
5.3 Biosense Technologies Pvt. Ltd.
5.4 Bisu Inc.
5.5 California Pacific Medical Center Research Institute
5.6 First Light Diagnostics Inc.
5.7 Healthy io Ltd.
5.8 Imperial College London
5.9 IRIS International Inc.
5.10 LifeAssays AB
5.11 NTBIO Diagnostics Inc.
5.12 Sebia S.A.
5.13 Siemens Healthineers AG
5.14 Stanford University
5.15 Sysmex Corp.
5.16 Teco Diagnostics
5.17 Trinity College Dublin
5.18 University of Kentucky
6 Urine Analysis - Recent Developments
6.1 Sep 25, 2019: UK urine test to detect early-stage pancreatic cancer starts clinical study
6.2 Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement
6.3 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report
6.4 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
6.5 Aug 14, 2019: Nymox Pharmaceutical: financial Results for the three and six months ended June 30, 2019
6.6 Aug 06, 2019: Blood clotting proteins discovered as biomarkers of Lupus Nephritis
6.7 Aug 01, 2019: Bio-Rad reports second-quarter 2019 financial results
6.8 Jul 29, 2019: Siemens Healthineers continues to drive growth forward
6.9 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers
6.10 Jul 24, 2019: Delaware District Court grants Bio-Rad’s Motion for Permanent Injunction against 10X Genomics
6.11 Jul 17, 2019: Healthy.io’s at-home, smartphone-based urinalysis test available in boots pharmacies across the U.K.
6.12 Jul 15, 2019: EKF Diagnostics Holdings: Trading update
6.13 Jul 11, 2019: Study finds Healthy.io’s At-Home, smartphone-based urinalysis feasible, preferred, and easy-to-use for women in prenatal care
6.14 May 27, 2019: Sysmex and Osaka University sign comprehensive collaboration agreement to foster innovation in the healthcare field
6.15 May 22, 2019: Serving the needs of the medical front and creating new value the start of a New Medical Device and Reagent Brand: The Lab
6.16 May 15, 2019: Nymox Pharmaceutical: Financial result for three months ended March 31, 2019
6.17 May 08, 2019: Bio-Rad reports first quarter 2019 financial results
6.18 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter
6.19 Apr 29, 2019: Urine test could prevent cervical cancer
6.20 Apr 22, 2019: Bio-Rad Laboratories names Andrew Last as executive vice president and chief operating officer
6.21 Apr 02, 2019: Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer
6.22 Apr 01, 2019: Mologic expands US and UK operations
6.23 Mar 19, 2019: Researchers develop new test for prostate cancer
6.24 Mar 19, 2019: Nymox Pharmaceutical names Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls
6.25 Mar 13, 2019: Nymox announces appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for company’s manufacturing operations
6.26 Mar 13, 2019: EKF Diagnostics Holdings: Final results
6.27 Mar 07, 2019: Mindray signs patient safety movement’s open data pledge & becomes 90th company to join to improve patient safety
6.28 Feb 28, 2019: Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results
6.29 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim
6.30 Feb 07, 2019: New home test for kidney damage shows promising results
6.31 Jan 10, 2019: ARKRAY Commences Overseas Remote Maintenance Services for Medical Devices
6.32 Jan 03, 2019: Bio-Rad finance chief to retire
6.33 Jan 03, 2019: Christine Tsingos announces plans to retire as CFO of Bio-Rad Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/ippun8
View source version on businesswire.com:https://www.businesswire.com/news/home/20191119005699/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: NORTH AMERICA EUROPE
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/19/2019 09:47 AM/DISC: 11/19/2019 09:47 AM